Opposition 91251194
OtherUSPTO
Opposition 91251194 at USPTO between H-e-B, LP and New Land Healthcare Holdings Inc., over the mark MYHEBEME, filed Sep 25, 2019. Status in the office record: other.
- Status
- Other
- Result
- Other
- Filed
- Sep 25, 2019
- Marks involved
- 14
Parties
Who is involved
The parties as named in the office record.
Respondent
New Land Healthcare Holdings Inc.
Timeline
How the case has moved
Dates from the USPTO record and the MYHEBEME filing.
MYHEBEME filed
Application 88376769 filed at the USPTO.Opposition filed
H-e-B, LP started opposition 91251194 at USPTO against MYHEBEME.
Marks
Marks involved
1 contested mark, 13 marks the challenger relies on.
| Mark | Role | Application | Office |
|---|---|---|---|
| MYHEBEME | Contested | 88376769 | USPTO |
| H E B | Relied on | 73727791 | USPTO |
| H-E-B | Relied on | 73727816 | USPTO |
| H-E-B | Relied on | 74400937 | USPTO |
| HEB | Relied on | 76116161 | USPTO |
| H-E-B | Relied on | 77022671 | USPTO |
| H-E-B | Relied on | 77022715 | USPTO |
| H-E-B | Relied on | 77915580 | USPTO |
| H E B | Relied on | 85539237 | USPTO |
| H-E-B | Relied on | 85545729 | USPTO |
| H- E- B | Relied on | 85548284 | USPTO |
| H -E- B | Relied on | 85693439 | USPTO |
+2 more marks in this case
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_2343e658-329f-4f07-bf6a-939d4ca8db07
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_2343e658-329f-4f07-bf6a-939d4ca8db07",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91251194",
"status": "other",
"office_code": "US",
"filed_date": "2019-09-25",
"parties": [
{
"name": "H-E-B, LP",
"role": "opponent"
},
{
"name": "New Land Healthcare Holdings Inc.",
"role": "respondent"
}
]
}